Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2026-03-01 @ 12:17 AM
Study NCT ID:
NCT01868061
Status:
COMPLETED
Last Update Posted:
2017-05-19
First Post:
2013-05-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-30
First Submit QC Date:
None
Study First Post Date:
2013-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-18
Last Update Post Date:
2017-05-19
Last Update Post Date Type:
ACTUAL